Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Enhanced Renal Clearance in Patients With Hemorrhagic Stroke.

Morbitzer KA, Jordan JD, Dehne KA, Durr EA, Olm-Shipman CM, Rhoney DH.

Crit Care Med. 2019 Jun;47(6):800-808. doi: 10.1097/CCM.0000000000003716.

PMID:
30870191
2.

The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.

Nelson NR, Morbitzer KA, Jordan JD, Rhoney DH.

Neurocrit Care. 2019 Feb;30(1):126-131. doi: 10.1007/s12028-018-0583-z.

PMID:
30051194
3.

Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.

Morbitzer KA, Jordan JD, Sullivan KA, Durr EA, Olm-Shipman CM, Rhoney DH.

Neurocrit Care. 2016 Oct;25(2):250-7. doi: 10.1007/s12028-016-0264-8.

PMID:
26942732
4.

The Role of Statin Therapy in Hemorrhagic Stroke.

Sikora Newsome A, Casciere BC, Jordan JD, Rhoney DH, Sullivan KA, Morbitzer KA, Moore JD, Durr EA.

Pharmacotherapy. 2015 Dec;35(12):1152-63. doi: 10.1002/phar.1674. Review.

PMID:
26684555
5.

Acute treatment of blood pressure after ischemic stroke and intracerebral hemorrhage.

Jordan JD, Morbitzer KA, Rhoney DH.

Neurol Clin. 2015 May;33(2):361-80. doi: 10.1016/j.ncl.2014.12.003. Epub 2015 Mar 17. Review.

PMID:
25907911
6.

Vancomycin pharmacokinetic parameters in patients with acute brain injury undergoing controlled normothermia, therapeutic hypothermia, or pentobarbital infusion.

Morbitzer KA, Jordan JD, Rhoney DH.

Neurocrit Care. 2015 Apr;22(2):258-64. doi: 10.1007/s12028-014-0079-4.

PMID:
25330755
7.

The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C.

Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD.

Clin Transplant. 2014 Aug;28(8):862-8. doi: 10.1111/ctr.12391. Epub 2014 Jun 20.

PMID:
24893750
8.

Hyponatremia in Patients with Spontaneous Intracerebral Hemorrhage.

Gray JR, Morbitzer KA, Liu-DeRyke X, Parker D, Zimmerman LH, Rhoney DH.

J Clin Med. 2014 Nov 20;3(4):1322-32. doi: 10.3390/jcm3041322.

9.

Aspirin for primary prevention of cardiovascular disease events.

Nemerovski CW, Salinitri FD, Morbitzer KA, Moser LR.

Pharmacotherapy. 2012 Nov;32(11):1020-35. doi: 10.1002/phar.1127. Epub 2012 Sep 27. Review.

PMID:
23019080

Supplemental Content

Loading ...
Support Center